John Michael Climaco Esq., J.D.
Net Worth

Last updated:

What is John Michael Climaco Esq., J.D. net worth?

The estimated net worth of Mr. John Michael Climaco Esq., J.D. is at least $2,467,202 as of 1 Feb 2024. He owns shares worth $1,197,002 as insider and has received compensation worth at least $1,270,200 in CNS Pharmaceuticals, Inc..

What is the salary of John Michael Climaco Esq., J.D.?

Mr. John Michael Climaco Esq., J.D. salary is $635,100 per year as Chairman, Chief Executive Officer & Pres in CNS Pharmaceuticals, Inc..

How old is John Michael Climaco Esq., J.D.?

Mr. John Michael Climaco Esq., J.D. is 56 years old, born in 1969.

What stocks does John Michael Climaco Esq., J.D. currently own?

As insider, Mr. John Michael Climaco Esq., J.D. owns shares in one company:

Company Title Shares Price per share Total value
CNS Pharmaceuticals, Inc. (CNSP) Chairman, Chief Executive Officer & Pres 215,676 $5.55 $1,197,002

What does CNS Pharmaceuticals, Inc. do?

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

CNSP logo
CNSP
CNS Pharmaceuticals, Inc.
$5.55

John Michael Climaco Esq., J.D. insider trading

CNS Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common stock 166,666 $0.3 $50,000
Purchase
Common Stock 2,750 $1.8 $4,945
Option
Common Stock 1,250 N/A N/A
Option
Restricted Stock Units 1,250 N/A N/A
Purchase
Common Stock 15,000 $0.69 $10,410

CNS Pharmaceuticals key executives

CNS Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Sandra L. Silberman M.D., Ph.D. (69) Chief Medical Officer
  • Mr. Christopher S. Downs CPA, CTP, FP&A (46) Chief Financial Officer
  • Mr. John Michael Climaco Esq., J.D. (56) Chairman, Chief Executive Officer & Pres